Manufacturing exosomes: a promising therapeutic platform

IL Colao, R Corteling, D Bracewell, I Wall - Trends in molecular medicine, 2018 - cell.com
Extracellular vesicles, in particular the subclass exosomes, are rapidly emerging as a novel
therapeutic platform. However, currently very few clinical validation studies and no clearly …

Technological aspects of manufacturing and analytical control of biological nanoparticles

S Brezgin, A Parodi, A Kostyusheva… - Biotechnology …, 2023 - Elsevier
Extracellular vesicles (EVs) are cell-derived biological nanoparticles that gained great
interest for drug delivery. EVs have numerous advantages compared to synthetic …

3D cell culture opens new dimensions in cell-based assays

BA Justice, NA Badr, RA Felder - Drug discovery today, 2009 - Elsevier
3D cell culture technologies have revolutionized our understanding of cellular behavior,
both in culture and in vivo, but adoption by cell-based screening groups has been slow …

Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions

F Santos, PZ Andrade, MM Abecasis… - … Engineering Part C …, 2011 - liebertpub.com
The immunomodulatory properties of mesenchymal stem cells (MSCs) make them attractive
therapeutic agents for a wide range of diseases. However, the highly demanding cell doses …

Attachment and detachment strategies in microcarrier-based cell culture technology: A comprehensive review

S Derakhti, SH Safiabadi-Tali, G Amoabediny… - Materials Science and …, 2019 - Elsevier
Achieving a high cell density of animal cells is a prerequisite for different medical
applications such as cell therapy, tissue engineering, and vaccine production. Microcarrier …

Stem cell cultivation in bioreactors

CAV Rodrigues, TG Fernandes, MM Diogo… - Biotechnology …, 2011 - Elsevier
Cell-based therapies have generated great interest in the scientific and medical
communities, and stem cells in particular are very appealing for regenerative medicine, drug …

Scalable stirred-suspension bioreactor culture of human pluripotent stem cells

DE Kehoe, D **g, LT Lock… - Tissue Engineering Part …, 2010 - liebertpub.com
Advances in stem cell biology have afforded promising results for the generation of various
cell types for therapies against devastating diseases. However, a prerequisite for realizing …

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

R Olmer, A Lange, S Selzer, C Kasper… - … Engineering Part C …, 2012 - liebertpub.com
Therapeutic and industrial applications of pluripotent stem cells and their derivatives require
large cell quantities generated in defined conditions. To this end, we have translated single …

Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics

M Wallen, F Aqil, W Spencer, RC Gupta - Cancer letters, 2023 - Elsevier
Chemotherapeutics continue to play a central role in the treatment of a wide variety of
cancers. Conventional chemotherapy involving bolus intravenous doses results in severe …

A xenogeneic‐free bioreactor system for the clinical‐scale expansion of human mesenchymal stem/stromal cells

F Dos Santos, A Campbell… - Biotechnology and …, 2014 - Wiley Online Library
The large cell doses (> 1× 106 cells/kg) used in clinical trials with mesenchymal
stem/stromal cells (MSC) will require an efficient production process. Moreover, monitoring …